The differences were attributed to batch inconsistency rather than container material
J Cell Biol 197:535551 Kenny PJ (2011) Common cellular and molecular mechanisms in obesity and drug addiction
In the HARMONY-2 (efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide) clinical study, patients were randomized to receive either once-weekly albiglutide (30 mg, titrated up to 50 mg if required for glycemic control) or 10 units of insulin glargine once daily
Extensively studied in research models for its role in metabolic signaling, body composition, and endocrine system regulation
They were not reducing their blood sugar levels more quickly
Among the 32 compounds that most strongly reduced bioluminescence, 31 did not alter persister frequencies, indicating that they probably suppressed bacterial metabolism rather than killing persisters (Supplementary Fig